Abstract
Amyloid β peptide (Aβ), 42-residue peptide and its variations, is known to form amyloid fibrils in Alzheimers disease. Solid-state NMR study reveals a parallel β-sheet structure in the Aβ fibrils. The atomic level structure of Aβ in aqueous environment, however, has not been determined, because of its tendency to aggregate. There are several reports that soluble forms of Aβ possess intrinsic neurotoxicity. It has recently become possible to determine the crystal structure of Aβ fragments in an aqueous solution without organic solvents and detergents using a fusion technique with a hyperthermophile protein. Aβ28-42 forms a β-conformation. This fusion technique enables us to obtain structural information at atomic resolution for amyloidogenic peptides in aqueous environments. This review describes our current knowledge on the Aβ conformation in aqueous environments and some viewpoints based on the knowledge.
Keywords: Alzheimer's disease, amyloid, monomer, structure, fusion technique
Current Alzheimer Research
Title: Amyloid β Conformation in Aqueous Environment
Volume: 5 Issue: 6
Author(s): K. Takano
Affiliation:
Keywords: Alzheimer's disease, amyloid, monomer, structure, fusion technique
Abstract: Amyloid β peptide (Aβ), 42-residue peptide and its variations, is known to form amyloid fibrils in Alzheimers disease. Solid-state NMR study reveals a parallel β-sheet structure in the Aβ fibrils. The atomic level structure of Aβ in aqueous environment, however, has not been determined, because of its tendency to aggregate. There are several reports that soluble forms of Aβ possess intrinsic neurotoxicity. It has recently become possible to determine the crystal structure of Aβ fragments in an aqueous solution without organic solvents and detergents using a fusion technique with a hyperthermophile protein. Aβ28-42 forms a β-conformation. This fusion technique enables us to obtain structural information at atomic resolution for amyloidogenic peptides in aqueous environments. This review describes our current knowledge on the Aβ conformation in aqueous environments and some viewpoints based on the knowledge.
Export Options
About this article
Cite this article as:
Takano K., Amyloid β Conformation in Aqueous Environment, Current Alzheimer Research 2008; 5 (6) . https://dx.doi.org/10.2174/156720508786898424
DOI https://dx.doi.org/10.2174/156720508786898424 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients
Current Pharmaceutical Design Citrus Peel Extract Attenuates Acute Cyanide Poisoning-Induced Seizures and Oxidative Stress in Rats
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Nutrition and Alzheimers Disease: Is There Any Connection? (Guest Editor: C. Ramassamy)]
Current Alzheimer Research Aqueous Humor Pharmacokinetics of Dorzolamide Loaded PLGAChitosan Nanoparticles by Ultra Performance Liquid Chromatography
Current Pharmaceutical Analysis Drug Design of Inhibitors of Alzheimer’s Disease (AD): POM and DFT Analyses of Cholinesterase Inhibitory Activity of β-amino di-Carbonyl Derivatives
Mini-Reviews in Medicinal Chemistry The IFN-λ Family (IL-28/29)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Epigenetic Modifications Due to Heavy Metals Exposure in Children Living in Polluted Areas
Current Genomics Effects of Engineered Type I Collagen on Hepatocyte Cultures
Current Nanoscience miR-7 Replacement Therapy in Parkinson’s Disease
Current Gene Therapy New Advances in the Field of Calcium Channel Antagonists: Cardiovascular Effects and Structure-Activity Relationships
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Myopericarditis, as the First Sign of Rheumatoid Arthritis Relapse, Evaluated by Cardiac Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) Establishment of Cholinergic Neuron-like Cell Lines with Differential Vulnerability to Nitrosative Stress
Current Neurovascular Research Medullary Thyroid Cancer: A Promising Model for Targeted Therapy
Current Molecular Medicine Conformations and Biological Activities of Amyloid Beta Peptide 25-35
Current Protein & Peptide Science Better Antiretroviral Central Nervous System Penetration is Not Associated with Reduced Chronic Pain in People Living with Human Immunodeficiency Virus
Anti-Infective Agents Chronotherapeutic Drug Delivery Systems - An Approach to Circadian Rhythms Diseases
Current Drug Delivery From A1 to A3 en passant Through A2A Receptors in the Hippocampus: Pharmacological Implications
CNS & Neurological Disorders - Drug Targets Evaluation of Adverse Drug Event Information in US Manufacturer Labels
Current Drug Safety Efforts to Understand the Molecular Basis of Hypertension Through Drug:Membrane Interactions
Current Topics in Medicinal Chemistry 4-Aminocyclopentane-1,3-diols as Platforms for Diversity: Synthesis of Anandamide Analogs
Medicinal Chemistry